Edwards Lifesciences Corp (EW)

NYSE


Symbol		Exchange		Currency
EW	·	NYSE	·	USD	Real-time
EW	·	Mexico	·	MXN	Delayed
1EW	·	Milan	·	EUR	Real-time
EW	·	TradeGate	·	EUR	Delayed
EW	·	Frankfurt	·	EUR	Delayed
E1WL34	·	B3	·	BRL	Delayed
EW	·	Vienna	·	EUR	Real-time

Currency in USD

EW Pro Research

75.87

-0.57(-0.75%)

Closed·13/02

After Hours

76.48+0.61(+0.80%)

·13/02

Fair Value

Unlock Value

Day's Range

75.51

77.56

52 wk Range

65.94

87.89

EW Income Statement

Assess the Edwards Lifesciences income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the EW net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

5,232.5

4,464

5,010

5,439.5

6,067.6

Total Revenues Growth

aa.aa

+19.29%

-14.69%

+12.23%

+8.57%

+11.55%

Cost Of Revenues

aa.aa

1,248.9

722.1

978.4

1,117.5

1,334.2

Gross Profit

aa.aa

3,983.6

3,741.9

4,031.6

4,322

4,733.4

Gross Profit Growth

aa.aa

+20.51%

-6.07%

+7.74%

+7.2%

+9.52%

Gross Profit Margin %

aa.aa

76.13%

83.82%

80.47%

79.46%

78.01%

Other Operating Expenses, Total

aa.aa

2,397.1

2,200.1

2,544.2

2,841.3

3,097.2

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+20.49%	-8.22%	+15.64%	+11.68%	+9.01%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	903.1	843.6	962.9	1,053	1,079.2
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,494	1,356.5	1,581.3	1,788.6	2,085.2
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-0.3	-67.2

Operating Income

aa.aa

1,586.5

1,541.8

1,487.4

1,480.7

1,636.2

Operating Income Growth

aa.aa

+20.54%

-2.82%

-3.53%

-0.45%

+10.5%

EBIT Margin %

aa.aa

30.32%

34.54%

29.69%

27.22%

26.97%

Net Interest Expenses

aa.aa

-1

16.3

49.6

100.5

148.4

Net Interest Expenses Growth

aa.aa

-113.16%

+1,730%

+204.29%

+102.62%

+47.66%

Interest Expense, Total

aa.aa

-18.4

-19.2

-17.6

-19.8

Interest And Investment Income

aa.aa

17.4

35.5

67.2

120.3

148.4

Other Non Operating Expenses, Total

aa.aa

15.8

13.4

13.9

7.2

EBT, Excl. Unusual Items

aa.aa

1,601.3

1,559.1

1,550.4

1,595.1

1,791.8

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

103.5

23.8

-177.3

-40.4

-501.5

EBT, Incl. Unusual Items

aa.aa

1,702

1,519.5

1,372.4

1,548.1

1,272.9

EBT, Incl. Unusual Items Growth

aa.aa

+85.67%

-10.72%

-9.68%

+12.8%

-17.78%

EBT, Incl. Unusual Items Margin

aa.aa

32.53%

34.04%

27.39%

28.46%

20.98%

Income Tax Expense

aa.aa

198.9

195.5

152.4

152.1

216.9

Net Income to Company

aa.aa

1,503.1

1,521.9

1,399.4

4,169.7

1,069.4

Minority Interest

aa.aa

4.9

4.1

Net Income

aa.aa

1,503.1

1,521.9

1,402.4

4,174.6

1,073.5

Net Income Growth

aa.aa

+82.55%

+1.25%

-7.85%

+197.68%

-74.28%

Net Income Margin %

aa.aa

28.73%

34.09%

27.99%

76.75%

17.69%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

1,503.1

1,324

1,223

1,400.9

1,060.1

Basic EPS - Continuing Operations

aa.aa

2.41

2.14

2.02

2.34

1.81

Basic EPS - Continuing Operations Growth

aa.aa

+82.34%

-11.3%

-5.76%

+16.27%

-22.66%

Diluted EPS - Continuing Operations

aa.aa

2.38

2.12

2.01

2.34

1.81

Diluted EPS - Continuing Operations Growth

aa.aa

+83.08%

-10.92%

-5.19%

+16.42%

-22.65%

Basic Weighted Average Shares Outstanding

aa.aa

623.3

619

606.7

597.7

584.8

Diluted Weighted Average Shares Outstanding

aa.aa

631.2

624.2

609.4

599.3

585.8

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

1,721.3

1,681.4

1,632.3

1,635.9

1,788.07

EBITDA Growth

aa.aa

+20.93%

-2.32%

-2.92%

+0.22%

+9.3%

EBITDA Margin %

aa.aa

32.9%

37.67%

32.58%

30.07%

29.47%

EBIT

aa.aa

1,586.5

1,541.8

1,487.4

1,480.7

1,636.2

* In Millions of USD (except for per share items)

FAQ

What was Edwards Lifesciences’s revenue at year end?

At the end of the last reported fiscal year, Edwards Lifesciences (EW) recorded total revenue of 6,067.60.

How much revenue did Edwards Lifesciences report in the most recent quarter?

In its most recent quarterly earnings report, Edwards Lifesciences posted revenue of 1,569.60.

What was Edwards Lifesciences’s net income for the year?

For the full year, Edwards Lifesciences reported net income of 1,073.50.

How much net income did Edwards Lifesciences post in the last quarter?

In the most recent quarter, Edwards Lifesciences (EW) posted net income of 91.20.

What was Edwards Lifesciences’s gross profit for the year?

Gross profit for the year was reported at 4,733.40.

How much gross profit did Edwards Lifesciences generate last quarter?

Edwards Lifesciences recorded gross profit of 1,226.60 in its latest quarterly report.

What was Edwards Lifesciences’s annual operating income?

For the full year, Edwards Lifesciences (EW) reported operating income of 1,636.20.

What was Edwards Lifesciences’s operating income last quarter?

Quarterly operating income was 370.30.

What was Edwards Lifesciences’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 409.50.

What was the quarter-over-quarter change in EBITDA for Edwards Lifesciences?

EBITDA changed by -11.80% compared to the last quarter.

What is Edwards Lifesciences’s most recent gross profit margin?

The latest reported gross profit margin for Edwards Lifesciences (EW) is 78.15%.

What is Edwards Lifesciences’s most recent net income margin?

Net income margin based on recent financials is 5.81%.

What is Edwards Lifesciences’s most recent EBIT margin?

Edwards Lifesciences reported an EBIT margin of 23.59% based on current figures.

How did Edwards Lifesciences’s revenue change compared to the previous quarter?

Revenue changed by 1.06% compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Edwards Lifesciences?

In the latest quarter 2026, gross profit changed by 1.55% from the previous quarter.

S&P/TSX

33,073.71

+608.43

+1.87%

S&P/TSX 60

1,917.15

+30.10

+1.60%

US 30

49,366.40

-134.5

-0.27%

US 500

6,807.20

-29.0

-0.42%

S&P 500 VIX

21.20

+0.60

+2.91%

DAX

24,800.91

-113.97

-0.46%

Dollar Index

97.02

+0.040

+0.04%

Market Movers

Name	Last	Chg. %	Vol.
Enbridge	73.30	+3.79%	11.56M
Barrick Mining	65.32	+5.63%	5.28M
Magna Intl	93.52	+18.94%	3.70M
Toronto Dominion Bank	129.93	-0.19%	3.48M
RBC	230.98	+0.21%	2.26M
Shopify Inc	153.88	+2.21%	2.23M
Bank of Montreal	192.17	+0.73%	1.62M

Name	Last	Chg. %	Vol.
PeakBirch Logic	0.030	+500.00%	1.32K
New Leaf Ventures	0.05	+400.00%	666.82K
Earthworks Industries	0.0300	+200.00%	1.18M
Transcontinental Gold	0.15	+200.00%	78.81K
Irwin Naturals	0.30	+150.00%	3.24K
Wedgemount Resources	0.05	+150.00%	164.66K
Torrent Gold	0.70	+129.51%	500.00

Name	Last	Chg. %	Vol.
XTM Inc	0.01	-100.00%	15.00K
Metamaterial	0.25	-92.86%	0.00
Planet Based Foods Global	0.01	-81.82%	35.00K
Puranium Energy	0.100	-79.17%	132.30K
Rivalry	0.02	-75.00%	1.62M
Riverwalk Acquisition	0.02	-57.14%	54.00K
TripSitter Clinic	0.07	-56.67%	155.01K

Trending Stocks

Name	Last	Chg. %	Vol.
TELUS	18.35	-3.22%	15.54M
Air Canada	20.25	+3.74%	6.21M
Constellation Software	2,356.67	+2.44%	118.75K
Celestica Inc.	381.72	+2.17%	364.98K
Canadian Natural	55.39	+1.76%	3.88M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaaaaaaaaaaaa	93.94	+62.53%	152.68
Aaaaaaaaaa	101.55	+49.42%	151.74
Aaaaaaaaa Aaaaaaa A	17.26	+47.35%	25.43
Aaaaaaaaaaa	27.48	+45.13%	39.88
Aaaaaaaaaaaaaaaaaaaa	8.17	+43.57%	11.73
Aaaaa Aaaaaaaaaaa	2,356.67	+42.24%	3,352.13
Aaaaaaa A Aa A Aaa	21.50	+40.44%	30.19

Name	Last	Upside	Fair Value
Aaaaaaaaaaaaaaa	93.94	+62.53%	152.68
Aaaaaaaaaa	101.55	+49.42%	151.74
Aaaaaaaaa Aaaaaaa A	17.26	+47.35%	25.43
Aaaaaaaaaaa	27.48	+45.13%	39.88
Aaaaaaaaaaaaaaaaaaaa	8.17	+43.57%	11.73
Aaaaa Aaaaaaaaaaa	2,356.67	+42.24%	3,352.13
Aaaaaaa A Aa A Aaa	21.50	+40.44%	30.19

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Edwards Lifesciences Corp (EW)

EW Income Statement

FAQ

What was Edwards Lifesciences’s revenue at year end?

How much revenue did Edwards Lifesciences report in the most recent quarter?

What was Edwards Lifesciences’s net income for the year?

How much net income did Edwards Lifesciences post in the last quarter?

What was Edwards Lifesciences’s gross profit for the year?

How much gross profit did Edwards Lifesciences generate last quarter?

What was Edwards Lifesciences’s annual operating income?

What was Edwards Lifesciences’s operating income last quarter?

What was Edwards Lifesciences’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Edwards Lifesciences?

What is Edwards Lifesciences’s most recent gross profit margin?

What is Edwards Lifesciences’s most recent net income margin?

What is Edwards Lifesciences’s most recent EBIT margin?

How did Edwards Lifesciences’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Edwards Lifesciences?

Trending Stocks